Additionally, upregulation of Wnt1 and β-catenin and attenuation of inducible nitric oxide synthase (iNOS) expression can be associated with neuroprotection in a mouse model of Parkinson’s disease [51]. This evidence concerns the gene NOS2 and Parkinson disease.